# Glaukos Corporation

- Location (FDA's records): San Clemente, CA
- FDA decisions: 4 (2012–2022): 2 510(k) clearances and 2 original PMA approvals
- Names in FDA's records: Glaukos Corporation (3); Glaukos (1)
- Product codes: OGO (2), KYF (1), MRH (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Allergan, Inc.: 1 (https://510kreport.com/company/allergan)
- Sight Sciences, Inc.: 1 (https://510kreport.com/company/sight-sciences)

## Recent decisions
- K220032: iStent infinite Trabecular Micro-Bypass System, Model iS3 (Aug 2, 2022)
- K212797: iPrime Viscodelivery System (Jan 6, 2022)
- P170043: iStent inject Trabecular Micro-Bypass System (Model G2-M-IS) (Jun 21, 2018)
- P080030: Glaukos Istent Trabecular Bypass Stent Model GTS100R/L (Jun 25, 2012)

Source page: https://510kreport.com/company/glaukos